Forecast
Period
|
2026-2030
|
Market
Size (2024)
|
USD
2.64 Billion
|
Market
Size (2030)
|
USD
4.13 Billion
|
CAGR
(2025-2030)
|
7.68%
|
Fastest
Growing Segment
|
Lancets
|
Largest
Market
|
North
America
|
Market Overview
Global Capillary Blood Collection
Devices Market was valued at USD 2.64 Billion in 2024 and is expected to reach USD
4.13 Billion by 2030 with a CAGR of 7.68% during the forecast period. The
global Capillary Blood Collection Devices market is driven by increasing demand
for minimally invasive diagnostic procedures, growing awareness of early
disease detection, and the rise in chronic diseases such as diabetes. Diabetes
is rapidly increasing worldwide, with the Middle East and Africa witnessing a
particularly concerning surge. The International Diabetes Federation (IDF)
predicts that the Middle East and North Africa will see a 110% rise in diabetes
cases, while Africa is expected to experience a 156% increase by 2045.Capillary
blood collection methods, like fingerstick testing, are gaining popularity due
to their ease of use, cost-effectiveness, and ability to provide rapid results.
Advancements in technology are improving the precision and efficiency of these
devices, boosting their adoption in home care and point-of-care settings. The
increasing preference for self-testing, coupled with the growing demand for
personalized healthcare solutions, is also contributing to market growth. The
rising focus on remote monitoring and healthcare accessibility further
accelerates the demand for capillary blood collection devices across various
regions.
Key Market Drivers
Rising
Prevalence of Chronic Diseases
The increasing prevalence of chronic
diseases, particularly diabetes, cardiovascular diseases, and other metabolic
disorders, is a primary driver of the Global Capillary Blood Collection
Devices Market. Diabetes, which requires continuous monitoring of blood
glucose levels, is one of the leading causes driving the demand for capillary
blood collection devices. According to WHO, in 2021,
noncommunicable diseases (NCDs) were responsible for at least 43 million
deaths, accounting for 75% of non-pandemic-related global fatalities. Of these,
18 million people died from an NCD before reaching the age of 70, with 82% of
these premature deaths occurring in low- and middle-income countries. Overall,
73% of all NCD-related deaths took place in these regions. Cardiovascular
diseases were the leading cause of NCD deaths, accounting for at least 19
million deaths in 2021, followed by cancers (10 million), chronic respiratory
diseases (4 million), and diabetes (over 2 million, including kidney disease
deaths linked to diabetes). Together, these four categories contributed to 80%
of all premature NCD deaths. Factors such as tobacco use, physical inactivity,
harmful alcohol consumption, poor diets, and air pollution increase the risk of
dying from an NCD. Key strategies in addressing NCDs include early detection,
screening, treatment, and palliative care.
As the global diabetes epidemic grows,
particularly in aging populations and regions with high rates of obesity and
sedentary lifestyles, more individuals require frequent blood testing to manage
their conditions effectively. Capillary blood collection methods, such as
lancets used for fingerstick testing, provide a fast and simple solution for
patients to measure blood glucose levels at home without needing to visit
healthcare facilities. The global aging population further contributes to this
rise, as older adults are more prone to chronic conditions that require regular
monitoring. Chronic diseases like hypertension and high cholesterol, which
often coexist with diabetes, also require routine testing, further driving the
demand for accessible and efficient blood collection methods. Consequently, the
need for capillary blood collection devices is directly correlated with the
increasing prevalence of chronic diseases, as these devices enable patients to
perform self-testing and receive timely information about their health,
ensuring better disease management and improved outcomes.
Cost-Effectiveness
and Accessibility
The cost-effectiveness and accessibility
of capillary blood collection devices are crucial factors driving the market's
growth. Capillary blood collection devices are generally more affordable than
traditional venous blood collection methods, making them more accessible to a
broader range of individuals, especially in low- and middle-income countries.
The devices are simple to use, portable, and require less training, making them
suitable for home healthcare, remote locations, and emergency settings. In addition
to being cost-effective, capillary blood collection devices are also more
time-efficient, providing quick results without the need for specialized
healthcare personnel or laboratory infrastructure. This accessibility is a key
factor in expanding their adoption across various segments of the population,
especially in areas with limited access to healthcare services. As the demand
for affordable healthcare solutions increases globally, the accessibility and
affordability of capillary blood collection devices are expected to remain
significant drivers of the market.
Technological
Advancements & Innovation
Technological advancements and
continuous innovations in capillary blood collection devices are major
contributors to the growth of the Global Capillary Blood Collection Devices
Market. In July 2022, Rhinostics introduced the VERIstic Collection Device,
designed to enable faster capillary blood collection. The device is equipped
with an integrated cap, which streamlines the process and saves time.
The development of new, more efficient,
and user-friendly devices is enhancing the adoption rate of these products. For
example, the design of lancet devices has evolved significantly over the years,
with improvements such as automatic depth adjustment, which reduces the
discomfort associated with blood collection. There has been a focus on making
devices more ergonomic and less invasive, providing patients with a more
comfortable experience. Advancements in accuracy and precision are also
contributing to the growth of the market. Devices are now capable of offering
more reliable results with minimal blood samples, which is essential for
monitoring chronic conditions such as diabetes, where accuracy is crucial for
effective treatment. The introduction of connected devices that sync with
mobile apps or cloud-based platforms for real-time data tracking further
enhances their appeal. These innovations enable healthcare professionals and
patients to track health data remotely, leading to more informed decisions and
better disease management. The integration of smart technologies into blood
collection devices is also opening up new opportunities for market expansion,
as it allows for continuous monitoring and early detection of health issues. As
these technologies evolve, they make capillary blood collection devices more
efficient, accessible, and user-friendly, driving market growth.
Growing
Healthcare Infrastructure and Awareness in Emerging Markets
The expansion of healthcare
infrastructure and the rising awareness about chronic diseases in emerging
markets such as Asia Pacific, South America, and the Middle East & Africa
are contributing significantly to the growth of the Global Capillary Blood
Collection Devices Market. Many emerging economies are seeing rapid
urbanization, improvements in healthcare systems, and rising healthcare
spending. As a result, more individuals in these regions are gaining access to
healthcare products and services that were previously limited. With rising
income levels and better healthcare access, people in these regions are more
likely to invest in self-monitoring solutions, such as capillary blood
collection devices, to manage their health. Healthcare awareness in these
regions is on the rise, with governments and NGOs increasingly focusing on
educating the population about the importance of early disease detection and
management, particularly for chronic conditions like diabetes and hypertension.
As these regions experience higher rates of chronic disease prevalence, there
is a growing demand for cost-effective, easy-to-use diagnostic tools, fueling
the adoption of capillary blood collection devices. Healthcare providers in
these regions are becoming more aware of the need for regular monitoring and
are recommending self-testing solutions for patients, further driving the
market. As awareness continues to rise, the demand for capillary blood
collection devices in emerging markets is expected to increase significantly in
the coming years.
Shift
Toward Preventive Healthcare
The global shift toward preventive
healthcare is playing an essential role in expanding the Global Capillary
Blood Collection Devices Market. Preventive healthcare focuses on disease
prevention, early detection, and improving overall health outcomes, which
requires regular health monitoring. Capillary blood collection devices enable
individuals to perform frequent health checks, such as blood glucose
monitoring, cholesterol testing, and other screenings that can identify risk
factors for chronic diseases. As healthcare systems worldwide move from a
reactive to a proactive approach, the demand for easy-to-use, reliable
self-testing devices is growing. The rise in preventive healthcare is supported
by initiatives from governments, insurance companies, and healthcare providers
who are increasingly encouraging individuals to take control of their health
through regular monitoring. For example, many health insurance providers offer
discounts or incentives to individuals who regularly monitor their health metrics.
This shift towards proactive health management, combined with the ease and
affordability of capillary blood collection devices, is a significant factor
driving the market. As more people adopt preventive healthcare practices, the
demand for home-based monitoring tools like capillary blood collection devices
is expected to grow.
Download Free Sample Report
Key Market Challenges
Regulatory
Challenges and Compliance
One of the key challenges facing the
Global Capillary Blood Collection Devices Market is the complex regulatory
environment that governs the approval, distribution, and use of medical
devices. Regulatory standards vary widely across different regions, and meeting
the requirements of agencies like the U.S. Food and Drug Administration (FDA),
European Medicines Agency (EMA), and other local regulatory bodies can be a
lengthy and costly process. Ensuring compliance with stringent safety and
quality standards is essential, but can be particularly challenging for manufacturers
looking to enter emerging markets, where regulations may be less defined or
constantly evolving. Any deviations in compliance or regulatory approval could
lead to product recalls or delays in market entry, significantly affecting the
financial performance of companies in the sector. The cost and time involved in
obtaining regulatory approvals can limit the pace of innovation and product
rollout, especially for smaller companies trying to compete with established
industry leaders.
Lack
of Standardization in Devices & Practices
Despite the growth of the Global
Capillary Blood Collection Devices Market, there is still a lack of
standardization in device designs and blood collection practices, which can
impact the reliability and accuracy of results. Capillary blood collection devices
are often used in diverse healthcare settings, from home care to hospitals, and
inconsistency in device quality and usage can result in variations in test
results. For example, the lancet depth, the angle of the blood collection, and
the site of the puncture can influence the sample quality. Healthcare
professionals may use devices incorrectly, leading to inadequate blood samples
and affecting diagnosis. This lack of standardization creates challenges in
ensuring that devices meet consistent performance benchmarks, which is critical
in diagnostic applications, particularly for conditions like diabetes where
accurate monitoring is essential for effective disease management. The absence
of universally accepted guidelines for capillary blood collection further
exacerbates this issue, making it more difficult for healthcare providers to
rely on these devices for consistent results across different patient groups.
Key Market Trends
Increasing
Adoption of Point-of-Care Diagnostics
The growing adoption of point-of-care
(POC) diagnostics is another critical driver of the Global Capillary
Blood Collection Devices Market. Point-of-care testing allows for the rapid
testing and analysis of blood samples outside of traditional laboratory
settings, making it a convenient and timely solution for both healthcare
providers and patients. In April 2023, Sensible Diagnostics revealed plans to
introduce a point-of-care (POC) PCR instrument capable of delivering PCR
results in just 10 minutes by 2024, initially focusing on infectious diseases.
Additionally, Abbott launched ID NOW, the world’s fastest molecular POC test,
which provides COVID-19 results in 13 minutes and can be utilized in various
healthcare settings, including doctor’s offices and urgent care clinics.
Furthermore, government initiatives aimed at controlling healthcare costs by
limiting the growth of infectious disease incidence are expected to act as a
key driver for this industry.
Capillary blood collection devices are
central to POC diagnostics, especially for conditions that require quick
results, such as diabetes, where patients need frequent blood glucose
monitoring. POC testing enables immediate decision-making, making it especially
beneficial in emergency situations and remote areas where access to labs may be
limited. As healthcare providers seek to improve patient outcomes through
faster diagnostic procedures, the demand for point-of-care devices is growing.
The expansion of POC diagnostic offerings in areas like pharmacies, home
healthcare, and ambulatory settings is fueling the adoption of capillary blood
collection devices. This trend is expected to continue as POC diagnostic
technology becomes more advanced, accurate, and affordable, further driving the
market for capillary blood collection devices.
Increased
Demand for Home Healthcare and Self-Monitoring
The growing demand for home healthcare
and self-monitoring is another significant factor propelling the Global
Capillary Blood Collection Devices Market. As patients become more informed
and empowered, there is a growing preference for managing health conditions in
the comfort of their homes. Capillary blood collection devices, which include
devices for blood glucose monitoring, cholesterol testing, and hemoglobin
monitoring, are increasingly being used in home healthcare settings. The
convenience of at-home testing eliminates the need for patients to visit
healthcare facilities regularly, reducing transportation costs and exposure to
infections, especially in the post-COVID era. The advancement of telemedicine
and mobile health apps that connect users with healthcare providers remotely
has made self-monitoring even more feasible and attractive. With chronic
conditions like diabetes requiring frequent monitoring, individuals now prefer
to have easy-to-use, compact, and accurate blood collection devices that allow
them to track their health status without the inconvenience of frequent doctor
visits. The shift towards self-care and home monitoring is not just a response
to global healthcare trends but also a means of empowering patients to take
control of their health, leading to increased adoption of capillary blood
collection devices. This trend is expected to continue growing as the world
moves toward more patient-centric healthcare systems and remote monitoring
solutions.
Segmental Insights
Product Insights
Based on the product, Lancets are
currently the dominant segment. Lancets are small, sharp devices primarily used
to puncture the skin to collect capillary blood for diagnostic testing,
especially for glucose monitoring in diabetic patients. They account for the
largest share of the market due to their simplicity, widespread use, and
effectiveness in facilitating easy blood collection. Lancets are favored
because they are minimally invasive and cause less discomfort compared to
traditional venous blood collection methods, which often require needles and more
extensive procedures. The ease of use is a significant factor contributing to
their dominance, particularly in home healthcare settings. Lancets are used for
routine blood tests like glucose monitoring, which is essential for individuals
managing chronic conditions such as diabetes. With the growing global
prevalence of diabetes and other chronic diseases that require regular
monitoring, the demand for lancets has been steadily increasing, particularly
in the self-care and home healthcare segments. Advancements in lancet
technology, such as adjustable depth control and spring-loaded mechanisms for
automatic activation, have improved patient comfort, making them even more
attractive. These innovations have made lancets a convenient and cost-effective
choice for both healthcare professionals and patients. The availability of
lancets in various forms—single-use, multi-use, and automated devices—further
enhances their appeal in the global market.
End Use Insights
Based on the end use segment, Hospitals
& Clinics are the dominant segment. Hospitals and clinics have long been
the primary settings for medical procedures, including blood collection, due to
their established infrastructure, experienced healthcare professionals, and
comprehensive diagnostic capabilities. The widespread use of capillary blood
collection devices in hospitals and clinics is driven by the need for routine
blood testing, particularly for chronic disease management, such as diabetes
monitoring.
Hospitals and clinics are key players in
the capillary blood collection devices market because they conduct a high
volume of diagnostic tests, from glucose monitoring for diabetes patients to
various other diagnostic tests requiring small blood samples. These healthcare
facilities are at the forefront of patient care and diagnostic services, making
them the primary consumers of lancets and other capillary blood collection
devices. The demand for devices like lancets in hospitals is driven by the need
for rapid, efficient blood collection methods that are minimally invasive and
cost-effective. Healthcare professionals in hospitals and clinics frequently
rely on capillary blood collection for patients who require frequent
monitoring, such as those with diabetes, newborns requiring neonatal screening,
and individuals undergoing pre-surgical tests. Hospitals and clinics are
equipped with the necessary infrastructure, such as trained healthcare
personnel, medical equipment, and laboratory facilities, to ensure efficient
blood collection and analysis. These facilities offer both inpatient and
outpatient care, leading to a high volume of blood collection procedures that
use capillary blood collection devices. The integration of these devices into
daily clinical practice has resulted in their widespread adoption, making them
a significant part of the routine diagnostic process. As hospitals focus on
improving patient outcomes, capillary blood collection devices are seen as an
effective way to gather crucial diagnostic information in a quick and minimally
invasive manner.
Download Free Sample Report
Regional Insights
North
America was the dominant region in the Global Capillary
Blood Collection Devices Market. This region leads the market due to
several factors, including the high prevalence of chronic diseases, advanced
healthcare infrastructure, a strong focus on self-monitoring, and the presence
of major market players. North America, particularly the United States, has a
well-established healthcare system that supports the widespread adoption of
capillary blood collection devices, especially for conditions like diabetes,
where regular blood glucose monitoring is crucial.
One of
the key drivers of market dominance in North America is the high rate of
chronic diseases, particularly diabetes. According to the Centers for Disease
Control and Prevention (CDC), over 34 million people in the U.S. are living
with diabetes, and approximately 88 million adults have prediabetes. This has
led to an increasing demand for devices that can help manage and monitor blood
glucose levels at home. Capillary blood collection devices, such as lancets and
blood glucose meters, have become essential tools for self-monitoring,
contributing to the growing adoption of these devices. The region’s strong healthcare
infrastructure also plays a critical role in market dominance. North America
has a vast network of hospitals, clinics, diagnostic centers, and home
healthcare services, all of which rely on capillary blood collection devices
for routine blood testing and monitoring. Hospitals and healthcare providers in
the U.S. and Canada frequently use lancets and other devices to conduct various
diagnostic tests, further expanding the market. The widespread adoption of
telemedicine and home healthcare services has fostered the growth of home
diagnosis, with patients utilizing capillary blood collection devices for
self-testing at home.
Recent Developments
- In July 2024, O'Ryan.Health unveiled two
pivotal studies: The JDM Study and The Healthy Kids Study, which focus on
at-home pediatric blood collection using capillary collection devices from
YourBio Health.
- In December 2023, BD obtained U.S. FDA
approval for its MiniDraw Capillary Blood Collection System. This device allows
for fingertip blood collection, providing accurate laboratory results.
- In December 2024, BD (Becton, Dickinson
and Company) announced the expansion of fingertip blood collection and testing
technologies for use across U.S. health systems and large provider networks,
including urgent care centers, doctor’s offices, and other ambulatory care
settings. This
innovative testing method combines BD's MiniDraw™ Capillary Blood Collection
System with Babson's BetterWay technologies, allowing test results to be
obtained from as little as six drops of capillary blood collected from a
patient's fingertip. This less-invasive approach to blood collection offers an
alternative to venipuncture, enabling more convenient sample collection.
- In April 2024, Babson Diagnostics successfully completed
validation testing for its hand-warming technology, designed to facilitate the
collection of high-quality blood samples from a fingertip. Hand warming is a
common technique used to improve blood collection from the fingertip. After
determining that existing off-the-shelf solutions did not meet customer needs,
Babson decided to develop its own technology. The company collaborated with
biomedical engineering experts specializing in the effects of heat on the human
body to design therapeutic devices tailored for this purpose.
Key Market Players
- Becton, Dickinson and Company
- Greiner Bio-One International GmbH
- Sarstedt Ag & Co. KG
- Terumo Medical Corporation
- B. Braun Melsungen AG
- Guangzhou Improve Medical
Instruments Co., Ltd
- Abbott Laboratories Inc.
- Cardinal Health, inc
- Retractable Technologies, Inc.
- Haemonetics Corporation
By
Product
|
By
Material
|
By
End Use
|
By
Application
|
By
Region
|
- Lancets
- Micro-container
Tubes
- Micro-hematocrit
Tubes
- Warming
Devices
- Others
|
- Plastic
- Glass
- Stainless
Steel
- Ceramic
- Others
|
- Hospitals
& Clinics
- Blood
Donation Centers
- Diagnostic
Centers
- Home
Diagnosis
- Pathology
Laboratories
|
- Whole
Blood
- Plasma/
Serum Protein Tests
- Comprehensive
Metabolic Panel (CMP) Tests
- Liver
Panel / Liver Profile/ Liver Function Tests
- Dried
Blood Spot Tests
|
- North
America
- Europe
- Asia
Pacific
- South
America
- Middle
East & Africa
|
Report Scope:
In this report, the
Global Capillary Blood Collection Devices Market
has been segmented into the following
categories, in addition to the industry trends which have also been detailed
below:
·
Capillary Blood Collection Devices Market, By Product:
o
Lancets
o
Micro-container Tubes
o
Micro-hematocrit Tubes
o
Warming Devices
o
Others
·
Capillary Blood Collection Devices Market, By Material:
o
Plastic
o
Glass
o
Stainless Steel
o
Ceramic
o
Others
·
Capillary Blood Collection Devices Market, By End Use:
o
Hospitals & Clinics
o
Blood Donation Centers
o
Diagnostic Centers
o
Home Diagnosis
o
Pathology Laboratories
·
Capillary Blood Collection Devices Market, By Application:
o
Whole Blood
o
Plasma/ Serum Protein Tests
o
Comprehensive Metabolic
Panel (CMP) Tests
o
Liver Panel / Liver
Profile/ Liver Function Tests
o
Dried Blood Spot Tests
· Capillary Blood
Collection Devices Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in the Global Capillary Blood
Collection Devices Market.
Available Customizations:
Global
Capillary Blood Collection Devices market report with the given market data, TechSci Research offers
customizations according to a company's specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
Global Capillary Blood Collection Devices Market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at sales@techsciresearch.com